PRPO

Healthcare Diagnostics & Research

Precipio, Inc.

$23.13

+0.40 +1.76% today

Price History

Not enough data

Key Stats

Market Cap

41.41M

Avg Volume

128,351

EPS

-$0.65

52W High

$33.63

52W Low

$16.40

Div. Yield

0.0%

Valuation

Forward P/E

59.31

P/B Ratio

2.80

P/S Ratio

1.52

EV/EBITDA

-324.96

EV/Revenue

1.54

Margins

Gross Margin 44.1%

Operating Margin (8.5%)

Net Margin (4.5%)

EBITDA Margin (0.5%)

Growth & Returns

Revenue Growth (YoY)

24.2%

Return on Equity

(9.0%)

Return on Assets

(4.8%)

Liquidity & Leverage

Current Ratio

1.77

Quick Ratio

1.45

Debt / Equity

0.24

Total Cash

3.08M

Total Debt

3.59M

About

Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers HemeScreen, a suite of robust genetic diagnostic panels; and IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages. It offers biomarker testing and clinical project services to bio-pharma customers. Precipio, Inc. is based in New Haven, Connecticut.